Preclinical research services (biotechnology and pharmacology):
- Pharmacology and Toxicology Testing: IC50 for Tumor Cell Lines
- Xenograft Animal Service: Immunocompromised NOD/SCID Mice
- Therapeutic RNAi Development: Targeted siRNA, qPCR Assays
- Liposome Encapsulation Services: siRNA, miRNA, DNA, Proteins
- ELISA and Cell-Based Assay Development (Cell Cycle, Viability)
- Apoptosis Assay: Caspase-3 and Caspase-7 Cell Line Screen
- RNAi Consulting: Technology Development and Evaluation
Development of stable cell lines services:
- Generation of Stable Cell Line in 28 Days
- Stable RNAi Cell Line Development: shRNA Gene Knockdown
- Protein overexpression: Mammalian stable cell line development
Cryopreservation and cell banking services:
- Cryopreservation and Cell Banking Service (GLP compliant)
- Cell Banking Service: Master Cell Bank (MCB, WCB) Generation
Contract research biology CRO services (GLP):
RNA interference (gene silencing) services:
- In Vivo siRNA Delivery and Tissue Targeting (In Vivo RNAi)
- Generation of Tetracycline-inducible RNAi Gene Knockdown Cell Lines
- PCR Cloning: DNA Vector Construction (shRNA)
- RNAi Manufacturing and CRO Services
- RNAi Screen Pathway Analysis: siRNA and microRNA
- Quantitation sh/siRNA-induced Knockdown by qRT-PCR and WB
- Genome-wide siRNA and microRNA High-throughput Screens
- Stable RNAi Cell Line Generation: Stable Gene Knockdown
- siRNA Transfection and RNAi Cell-based Library Screening
- siRNA Liposome Encapsulation Service
- Transient (siRNA) and Stable (shRNA) Transfection Services
Microorganism identification (16s sequencing) services: